We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+1.24%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.1B
AUM Growth
+$312M
Cap. Flow
-$44.8M
Cap. Flow %
-0.37%
Top 10 Hldgs %
38.76%
Holding
1,279
New
83
Increased
328
Reduced
404
Closed
81

Sector Composition

Rank Sector Weight
1 Real Estate 72.69%
2 Technology 4.79%
3 Financials 3.72%
4 Healthcare 2.91%
5 Industrials 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AERI
1076
DELISTED
Aerie Pharmaceuticals
AERI
$6K ﹤0.01%
261
-28
-10% -$580
LMNX
1077
DELISTED
Luminex Corp
LMNX
$6K ﹤0.01%
254
-30
-11% -$619
AKBA icon
1078
Akebia Therapeutics
AKBA
$343M
$5K ﹤0.01%
740
AMPH icon
1079
Amphastar Pharmaceuticals
AMPH
$846M
$5K ﹤0.01%
265
-31
-10% -$595
ATRA icon
1080
Atara Biotherapeutics
ATRA
$69.5M
$5K ﹤0.01%
12
-2
-14% -$690
OPK icon
1081
Opko Health
OPK
$936M
$5K ﹤0.01%
3,729
SGMO
1082
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$5K ﹤0.01%
654
-72
-10% -$662
STOK icon
1083
Stoke Therapeutics
STOK
$1.83B
$5K ﹤0.01%
+185
New +$4.65K
VNDA icon
1084
Vanda Pharmaceuticals
VNDA
$314M
$5K ﹤0.01%
301
-34
-10% -$514
QTTB icon
1085
Q32 Bio
QTTB
$452M
$5K ﹤0.01%
14
-2
-13% -$573
RVNC
1086
DELISTED
Revance Therapeutics, Inc.
RVNC
$5K ﹤0.01%
280
AXNX
1087
DELISTED
Axonics, Inc. Common Stock
AXNX
$5K ﹤0.01%
+192
New +$4.58K
EGRX
1088
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$5K ﹤0.01%
82
ENDP
1089
DELISTED
Endo International plc
ENDP
$5K ﹤0.01%
1,280
-147
-10% -$656
RDUS
1090
DELISTED
Radius Health, Inc.
RDUS
$5K ﹤0.01%
261
-29
-10% -$704
DERM
1091
DELISTED
Dermira, Inc.
DERM
$5K ﹤0.01%
308
-39
-11% -$337
ACHN
1092
DELISTED
Achillion Pharmaceuticals
ACHN
$5K ﹤0.01%
890
CY
1093
PUT
DELISTED
Cypress Semiconductor
CY
$5K ﹤0.01%
+100
New +$2.34K
ADVM
1094
DELISTED
Adverum Biotechnologies
ADVM
$4K ﹤0.01%
37
-4
-10% -$353
AKRO
1095
DELISTED
Akero Therapeutics
AKRO
$4K ﹤0.01%
+161
New +$3.33K
ANIP icon
1096
ANI Pharmaceuticals
ANIP
$1.78B
$4K ﹤0.01%
68
-8
-11% -$530
CERS icon
1097
Cerus
CERS
$615M
$4K ﹤0.01%
871
COLL icon
1098
Collegium Pharmaceutical
COLL
$1.15B
$4K ﹤0.01%
180
CYTK icon
1099
Cytokinetics
CYTK
$10.9B
$4K ﹤0.01%
363
DTIL icon
1100
Precision BioSciences
DTIL
$187M
$4K ﹤0.01%
+10
New +$3.14K

Similar funds

Daiwa Securities Group's Q4 2019 Portfolio in Review

As of Q4 2019, Daiwa Securities Group held 1,279 positions worth $12.1B, up 2.6% from $11.8B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Daiwa Securities Group's Q4 2019 filing shows 83 new, 328 increased, 404 reduced and 81 closed positions. Its largest new stake was Performance Food Group: 109,263 shares worth $5.63M. The largest sale was Sun Communities, an estimated $208M.

By sector, the portfolio is most concentrated in Real Estate at 73% of assets, down from 73% a quarter earlier, followed by Technology and Financials.

  • Daiwa Securities Group's largest Q4 2019 buy was Performance Food Group: 109,263 shares worth $5.63M.
  • Daiwa Securities Group added most to Digital Realty Trust in Q4 2019, an estimated $239M increase.
  • Daiwa Securities Group's biggest Q4 2019 reduction was Sun Communities, cutting an estimated $208M.
  • Daiwa Securities Group fully exited State Street SPDR S&P 500 ETF Trust in Q4 2019, selling an estimated $13.1M.
  • Daiwa Securities Group's ten largest holdings make up 39% of its $12.1B portfolio in Q4 2019.
  • Daiwa Securities Group opened 83 new positions and closed 81 in Q4 2019.
  • Daiwa Securities Group's portfolio value rose 2.6% quarter-over-quarter to $12.1B.

Based on Daiwa Securities Group's 13F filing for Q4 2019, filed 31 Jan 2020.